Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Hepatol Commun ; 2(4): 376-392, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29619417

RESUMO

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of atherosclerotic cardiovascular disease. In our meta-analysis, we aimed to assess the correlation of NAFLD and four surrogate markers of subclinical atherosclerosis. PubMed, Embase, and the Cochrane Library were searched up until April 2017. Original studies investigating the association between NAFLD and subclinical atherosclerosis were included. The outcome data were extracted and pooled for the effect estimate by using a random-effects model. We used the Newcastle-Ottawa Quality Assessment Scale to assess the quality of the included studies. Of the 434 initially retrieved studies, 26 studies involving a total of 85,395 participants (including 29,493 patients with NAFLD) were included in this meta-analysis. The Newcastle-Ottawa Quality Assessment Scale scores suggested the included studies were of high quality. The pooled effects estimate showed that subjects with NAFLD exhibited a significant independent association with subclinical atherosclerosis compared to the non-NAFLD group (odds ratio, 1.60; 95% confidence interval, 1.45-1.78). Subgroup analysis suggested that the presence of NAFLD yielded a remarkable higher risk of increased carotid artery intima-media thickness/plaques, arterial stiffness, coronary artery calcification, and endothelial dysfunction with odds ratios (95% confidence interval) of 1.74 (1.47-2.06), 1.56 (1.24-1.96), 1.40 (1.22-1.60), and 3.73 (0.99-14.09), respectively. Conclusion: Our meta-analysis revealed a close link between NAFLD and subclinical atherosclerosis in light of four different indices. Patients with NAFLD might benefit from screening and surveillance of early atherosclerosis, which would facilitate the prediction of potential cardiovascular disease burden, risk stratification, and appropriate intervention in the long term. (Hepatology Communications 2018;2:376-392).

2.
Eur J Gastroenterol Hepatol ; 30(6): 631-636, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29351115

RESUMO

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has been linked to an increased risk of cardiovascular disease (CVD). To explore the impact of diabetes mellitus (DM) as a cardiovascular risk factor, this meta-analysis quantitatively assessed the association of NAFLD and CVD in diabetic patients. METHODS: PubMed, EMBASE, and the Cochrane Library database were analyzed until the end of March 2017. Original studies analyzing the association between NAFLD and cardiovascular risk factors in the diabetic population were included. The available data related to outcome were extracted for the effect estimate using a random-effects model. The quality of the included studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. RESULTS: Of the 770 initially identified studies, 11 studies involving 8346 patients were finally included. The Newcastle-Ottawa Quality Assessment Scale scores suggested that the studies included were of high quality. The pooled effects estimate showed that diabetic patients with NAFLD showed a two times increased risk for CVD compared with patients without NAFLD (odds ratio=2.20, 95% confidence interval: 1.67-2.90). Subgroup analysis also yielded a markedly increased risk, with odds ratio (95% confidence interval) values of 2.28 (1.61-3.23) and 1.90 (1.48-2.45) in cross-sectional and cohort studies, respectively. CONCLUSION: This is the first meta-analysis investigating the relationship between NAFLD and CVD independent of the impact of DM. Our findings suggested that NAFLD increases the risk of CVD in populations with comparable DM profiles. Diabetic patients diagnosed with NAFLD might benefit from a more early cardiovascular risk assessment, thereby reducing CVD morbidity and mortality.


Assuntos
Doenças Cardiovasculares/epidemiologia , Diabetes Mellitus/epidemiologia , Hepatopatia Gordurosa não Alcoólica/epidemiologia , Fatores Etários , Doenças Cardiovasculares/diagnóstico , Distribuição de Qui-Quadrado , Comorbidade , Diabetes Mellitus/diagnóstico , Feminino , Humanos , Estilo de Vida , Masculino , Análise Multivariada , Hepatopatia Gordurosa não Alcoólica/diagnóstico , Razão de Chances , Prevalência , Prognóstico , Medição de Risco , Fatores de Risco , Fatores Sexuais
3.
Sci Rep ; 6: 33743, 2016 09 19.
Artigo em Inglês | MEDLINE | ID: mdl-27642100

RESUMO

Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We aimed to compare the use of different antidiabetic strategies and the incidence of HCC. PubMed, Embase.com and Cochrane Library databases were searched up to 31 October 2015 and randomized controlled trials (RCTs), cohort studies or case-control studies were included for our analyses. A total of thirteen studies enrolling 481358 participants with 240678 HCC cases who received at least two different strategies were retrieved in this analysis. Direct comparisons showed that use of metformin (risk ratio [RR] 0.49, 95% CI 0.25-0.97) was associated with a significant risk reduction of HCC, while insulin (RR = 2.44, 95% CI 1.10- 5.56) may significantly increase the risk. Indirect evidence also suggested that insulin (RR = 2.37, 95% CI 1.21-4.75) was associated with a significantly increased risk of HCC. Additionally, metformin was effective in reducing the risk of HCC when compared with sulphonylurea (RR = 0.45, 95% CI 0.27-0.74) and insulin (RR = 0.28, 95% CI 0.17-0.47). Notably, metformin was hierarchically the best when compared with other antidiabetic therapies for the prevention of HCC. In summary, available evidence suggests that metformin was the most effective strategy to reduce HCC risk when compared with other antidiabetic interventions.


Assuntos
Carcinoma Hepatocelular , Hipoglicemiantes/efeitos adversos , Hipoglicemiantes/uso terapêutico , Neoplasias Hepáticas , Metformina/uso terapêutico , Carcinoma Hepatocelular/induzido quimicamente , Carcinoma Hepatocelular/prevenção & controle , Feminino , Humanos , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/prevenção & controle , Masculino , Fatores de Risco
4.
Huan Jing Ke Xue ; 37(3): 816-24, 2016 Mar 15.
Artigo em Chinês | MEDLINE | ID: mdl-27337871

RESUMO

In January 2013 large-scale, continuous and severe haze occurred in Nanjing. Three-wavelength photoacoustic soot spectrometer (PASS-3) was used for real-time, online and situ measurements of aerosol absorption and scattering coefficients in the northern suburb of Nanjing during January 2013. The results indicated that the average aerosol absorption and scattering coefficients were (83.20 ± 35.24) Mm⁻¹ and (670.16 ± 136.44) Mm⁻¹ during haze days, which were 3.85 and 3.45 times higher than those on clean days, respectively. The diurnal variation of absorption and scattering coefficients showed a bimodal distribution. The mean single scattering albedo and scattering Angstrom exponent were (0.89 ± 0.04) and (1.30 ± 0.27) respectively, indicating the predominance of scattering fine particles during haze days in Nanjing. Aerosols could be significantly removed by precipitation. The absorption and scattering coefficients showed negative correlations with surface wind speed, and the single scattering albedo and Angstrom exponent showed positive correlations with wind speed. Aerosol scattering coefficient was highest under southeasterly wind, whereas the absorption coefficient was highest under the southwesterly wind. In the three haze pollution events, Haze 1 and Haze 2 were mainly affected by long-range transportation of pollutants. Haze 1 was mainly affected by aging air mass from north Nanjing, Haze 2 was mainly affected by biomass burning air mass from southwest Nanjing, while Haze 3 was mainly caused by the high sulfate.


Assuntos
Aerossóis/análise , Poluentes Atmosféricos/análise , Monitoramento Ambiental , Biomassa , China , Tamanho da Partícula , Fuligem/análise , Sulfatos/análise , Vento
5.
Oncotarget ; 7(16): 21753-62, 2016 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-26943041

RESUMO

OBJECTIVES: Usage of statins is suggested to decrease the incidence of HCC. When it comes to different statin subtypes, the chemopreventive action remains controversial. We aim to compare the usage of different statins and reduction of HCC risk. METHODS: We searched PubMed, Embase.com and Cochrane Library database up to August 10, 2015. Duplicated or overlapping reports were eliminated. We performed a traditional pair-wise meta-analysis and a Bayesian network meta-analysis to compare different treatments with a random-effects model. RESULTS: We reviewed five observational studies enrolling a total of 87127 patients who received at least two different treatment strategies including rosuvastatin, atorvastatin, simvastatin, pravastatin, fluvastatin, cerivastatin, and lovastatin or observation alone. Direct comparisons showed that usage of atorvastatin (OR 0.63, 95%CI 0.45-0.89) and fluvastatin (OR 0.58, 95%CI 0.40-0.85) could significantly cut the risk of liver cancer. The difference of indirect comparisons between the included regimens is not statistically significant. However, usage of all types of statins, such as fluvastatin (RR 0.55, 95%CI 0.26-1.11), atorvastatin (RR 0.59, 95%CI 0.30-1.16), simvastatin (RR 0.69, 95%CI 0.38-1.25), cerivastatin (RR 0.71, 95%CI 0.19-2.70), pravastatin (RR 0.72, 95%CI 0.37-1.45), lovastatin (RR 0.81, 95%CI 0.34-1.96) and rosuvastatin (RR 0.92, 95%CI 0.44-1.80), appeared to be superior to observation alone. Notably, fluvastatin was hierarchically the best when compared with the six other statins. CONCLUSIONS: Our analyses indicate the superiority of usage of statins in reduction of liver cancer. Available evidence supports that fluvastatin is the most effective strategy for reducing HCC risk compared with other statin interventions.


Assuntos
Carcinoma Hepatocelular/tratamento farmacológico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Neoplasias Hepáticas/tratamento farmacológico , Fígado/efeitos dos fármacos , Atorvastatina/uso terapêutico , Teorema de Bayes , Quimioterapia Combinada , Ácidos Graxos Monoinsaturados/uso terapêutico , Fluvastatina , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/classificação , Indóis/uso terapêutico , Fígado/patologia , Lovastatina/uso terapêutico , Estudos Observacionais como Assunto , Pravastatina/uso terapêutico , Piridinas/uso terapêutico , Rosuvastatina Cálcica/uso terapêutico , Sinvastatina/uso terapêutico , Resultado do Tratamento
6.
Huan Jing Ke Xue ; 36(6): 1926-34, 2015 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-26387291

RESUMO

To investigate the characteristics of water-soluble ions in PM2.5 and their contribution to light extinction in haze days, on-line monitoring of PM2.5. was conducted at North Suburban Nanjing from 25 January through 3 February, 2013. Water-soluble components were collected with a particle-into-liquid sampler (PILS), and analyzed by ion chromatography (IC) for the contents of SO4(2-), NO3-, NH4+, Cl-, Na+, K+, Mg2+ and Ca2+ Simultaneously particle size distributions were measured using scanning mobility particle sizer (SMPS) and Aerodynamic Particle Sizer (APS). The absorption and scattering coefficients were measured by three-wavelength photoacoustic soot spectrometer (PASS-3). Trace gases (SO2, NO2 etc.) were also monitored. The results showed that the average concentrations of total water-soluble ions were 70.3 and 22.9 microg x m(-3) in haze and normal days, respectively. Secondary hygroscopic components including SO4(2-), NO3- and NH4+ were the major ionic pollutants. Hazy days favored the conversion of SO2 and NOx, to SO4(2-) and NO3-, respectively, and in particular the oxidation of NOx. Using multiple linear regression statistical method, the empirical relationship between the dry aerosol extinction coefficient and the chemical composition was established. NH4NO3 was found to be the largest contributor to aerosol extinction in winter in Nanjing, followed by (NH4)2SO4, OC and EC. In two heavy pollution events, the increase of ion concentrations was influenced by the increase of primary emissions and secondary transformation.


Assuntos
Poluentes Atmosféricos/análise , Material Particulado/análise , Aerossóis , China , Cidades , Monitoramento Ambiental , Gases , Íons , Luz , Tamanho da Partícula , Estações do Ano , Solubilidade , Água
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA